Biblio Discovery — Demo Discovery Service

3 results for "Eric Lefebvre"

Showing 1–3 · 0.63 seconds · RSS

  1. Journal Article Full text

    Differential impact of the dual CCR2/CCR5 inhibitor cenicriviroc on migration of monocyte and lymphocyte subsets in acute liver injury

    Tobias Puengel; Oliver Krenkel; Marlene Kohlhepp et al.

    PLOS ONE, Vol. 12 No. 9 · 2017 · English · PLOS Scopus

    A hallmark of acute hepatic injury is the recruitment of neutrophils, monocytes and lymphocytes, including natural killer (NK) or T cells, towards areas of inflammation. The recruitment of leukocytes from their reservoirs bone marrow or spleen into the liver is directed by chemokines such as CCL2…

  2. Journal Article Full text

    Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical Isolates

    Benoit Visseaux; Charlotte Charpentier; Gilles Collin et al.

    PLOS ONE, Vol. 10 No. 8 · 2015 · English · PLOS Scopus

    Background: Maraviroc activity against HIV-2, a virus naturally resistant to different HIV-1 antiretroviral drugs, has been recently demonstrated. The aim of this study was to assess HIV-2 susceptibility to cenicriviroc, a novel, once-daily, dual CCR5 and CCR2 antagonist that has completed Phase 2b…

  3. Journal Article Full text

    Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis

    Eric Lefebvre; Graeme Moyle; Ran Reshef et al.

    PLOS ONE, Vol. 11 No. 6 · 2016 · English · PLOS Scopus

    Background & Aims: Interactions between C-C chemokine receptor types 2 (CCR2) and 5 (CCR5) and their ligands, including CCL2 and CCL5, mediate fibrogenesis by promoting monocyte/macrophage recruitment and tissue infiltration, as well as hepatic stellate cell activation. Cenicriviroc (CVC) is an…